Myeloma research group
1 – 10 of 30
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosus (
- Genetic predisposition for multiple myeloma (
- Search for multiple myeloma risk factors using Mendelian randomization (
- Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels (
- Outcome and characteristics of non-measurable myeloma : A cohort study with population-based data from the Swedish Myeloma Registry (
- Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression : A prospective, open-label, multicenter, randomized, phase 3 study (
- Increased Frequencies of Switched Memory B Cells and Plasmablasts in Peripheral Blood from Patients with ANCA-Associated Vasculitis (
- 2019
- Aspects of Phagocyte Function in Multiple Myeloma (
- All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma (
- Sequence variation at the MTHFD1L-AKAP12 and FOPNL loci does not influence multiple myeloma survival in Sweden (